Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
Top Cited Papers
- 1 November 2008
- journal article
- clinical trial
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 68 (11), 1739-1745
- https://doi.org/10.1136/ard.2008.092833